Pre-market Movers: HZNP, RVP, SFR, TMDX, CRWD…

Monks Investment Trust Posts HY Loss

The Monks Investment Trust PLC (MNKS.L) reported that its net loss for the six months to 31 October 2022 was 158.28 million pounds or 71.03 pence per share compared to net return on ordinary activities after taxation of 208.43 million pounds or 88.15 pence per share in the prior year.

Income from investments and interest receivable for the period was 15.93 million pounds down from 16.02 million pounds in the previous year.

No interim dividend is being paid. A single final dividend will typically be paid after the AGM, the company said in a statement.

MS International H1 Pretax Profit Rises – Quick Facts

MS International PLC (MSI.L) reported that its first-half profit before tax increased
to 3.46 million pounds from 0.8 million pounds, last year. Earnings per share was 16.8 pence compared to 3.3 pence. Revenue increased to 42.02 million pounds from 33.15 million pounds, previous year.

The Group stated that its balance sheet is significantly stronger with cash at 23.88 million pounds.

The Board has declared an increased interim dividend per share of 2 pence, payable to shareholders on 13th January 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit

Indivior Expects Double-digit Percentage Net Revenue CAGR Over Medium-term

Indivior Plc. (INDV.L) expects to achieve double-digit percentage net revenue compounded annual growth rate (CAGR) over the medium-term. The company reiterated its 2022 guidance.

The company said it will hold a Capital Markets Day Wednesday in New York City. The event will be hosted by Mark Crossley, Chief Executive Officer, along with members of the Indivior executive leadership team and will detail the company’s strategic growth plans and roadmap for delivering long-term shareholder value.

Indivior expects SUBLOCADE (buprenorphine extended-release) injection to achieve a net revenue run rate of $1 billion by the end of 2025. It now expects to deliver SUBLOCADE peak potential net revenue of more than $1.5 billion.

Indivior expects to achieve a double-digit percentage net revenue CAGR over the medium-term, driven primarily by SUBLOCADE in the United States and growing net revenue contribution from PERSERIS (risperidone for extended-release injection).

Indivior expects to achieve significant operating margin expansion over the medium-term driven by an improving gross margin and focused management of operating expenses.

At its Extraordinary General Meeting in September of this year, Indivior received strong support from its shareholders for an additional share listing in the United States. It has chosen NASDAQ as its U.S. trading venue, the company said. The listing on NASDAQ is targeted for the Spring of 2023.

Oil Prices Extend Losses On Recession Worries

Oil prices fell further on Wednesday, after having tumbled to an 11-month low in the previous session on concerns about the outlook for energy demand.

Benchmark Brent crude futures fell nearly 2 percent to $77.82 a barrel, while WTI crude futures were down 1.8 percent at $72.90.

Recession worries gripped financial markets after top U.S. banks warned of a recession in 2023 and China reported weak trade balance figures for November.

Chinese shipments registered an annual decrease of 8.7 percent in November, data from the General Administration of Customs revealed.

Economists had expected a moderate 3.6 percent drop in exports after a 0.3 percent easing in October. This was the second consecutive fall and also the largest since early 2020.

Likewise, imports to China decreased the most since the middle of 2020 – stirring fresh worries about fuel demand in the world’s second-largest economy.

Imports fell 10.6 percent annually, bigger than the expected 5.0 percent fall and October’s 0.7 percent decrease.

Meanwhile, investors ignored industry data showing that crude oil inventories dropped for the fourth week in a row last week.

The American Petroleum Institute estimated a drawdown in U.S. crude stockpiles of around 6.4 million barrels, suggesting demand remained strong in the world’s largest consumer.

The official numbers from the Energy Information Administration are due later in the session.

36Kr Holdings Turns To Profit In Q3; Total Revenues Up 11.5%

36Kr Holdings Inc. (KRKR) reported third-quarter non-GAAP adjusted net income of RMB 5.1 million in the third quarter compared to an adjusted net loss of RMB 26.4 million, prior year.

Net income attributable to shareholders was RMB 1.7 million, compared to a net loss attributable to shareholders of RMB 30.5 million, last year. Net income per ADS was RMB 0.042, compared to a loss per ADS of RMB 0.746.

Total revenues increased by 11.5% to RMB 94.6 million. Number of followers as of September 30, 2022 reached 26.8 million.

For more earnings news, earnings calendar, and earnings for stocks, visit

Pre-market Movers: HZNP, RVP, SFR, TMDX, CRWD…

The following are some of the stocks making big moves in Wednesday’s pre-market trading (as of 07.40 A.M. ET).

In the Green

Horizon Therapeutics Public Limited Company (HZNP) is up over 33% at $104.80
Retractable Technologies, Inc. (RVP) is up over 31% at $2.69
Starwood Waypoint Homes of Ben (SFR) is up over 19% at $12.89
TransMedics Group, Inc. (TMDX) is up over 18% at $68.99
Longeveron Inc. (LGVN) is up over 17% at $4.29
Viridian Therapeutics, Inc. (VRDN) is up over 15% at $26.40
Mesoblast Limited (MESO) is up over 9% at $3.50

In the Red

CrowdStrike Holdings, Inc. (CRWD) is down over 17% at $113.70
OncoSec Medical Incorporated (ONCS) is down over 15% at $3.26
Newpark Resources, Inc. (NR) is down over 14% at $3.37
Arcimoto, Inc. (FUV) is down over 13% at $7.06
NetApp, Inc. (NTAP) is down over 10% at $64.01
Aspen Aerogels, Inc. (ASPN) is down over 10% at $10.10